Regulatory Genome Development raised €5.5M in a Seed round in Apr 2022. The company is based in Cambridge, UK. Investors in the round: AlbionVC, Cambridge Enterprise, Evolution Equity Partners and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
